Rationale and design of the Rockford CHIP, a community-based coronary risk reduction program: Results of a pilot phase

Preventive Medicine

Volumn 38, Issue 4, 2004, Pages 432-441

  Englert, Heike S ^a,d   Diehl, Hans A ^b,c   Greenlaw, Roger L ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Lifestyle Medicine Institute   (United States)

^c SwedishAmerican Center for Complementary Medicine   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cholesterol; Community based health intervention strategies; Coronary risk reduction; Diabetes; Diet; Healthy communities; Hypertension; Lifestyle medicine; Obesity; Public health; Self care

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; FAT; GLUCOSE; LOW DENSITY LIPOPROTEIN; PROTEIN; SODIUM CHLORIDE; SUGAR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CAUCASIAN; COMMUNITY CARE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; CURRICULUM; DIABETES MELLITUS; DIET; EXERCISE; FEASIBILITY STUDY; FEMALE; FIBER; GENERAL CONDITION IMPROVEMENT; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH EDUCATION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NUTRITION; OBESITY; ORGANIZATION; PILOT STUDY; PLANT; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; AGED; CORONARY DISEASE; EXERCISE; FEASIBILITY STUDIES; FEMALE; FOOD HABITS; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 1542358721     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2003.11.007     Document Type: Article

References (43)

1. Diehl H.A. Reversing coronary artery disease. Temple N.J., Burkitt D.P. Western diseases: their dietary prevention and reversibility. 1994;237-316 Humana Press, Totowa.
2. Roberts W.C. Preventing and arresting coronary atherosclerosis. Am. Heart J. 130:1995;580-600.
3. Brown B.G., Zhao X.-Q., Sacco D.E., Albers J.J. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 87:1993;1781-1791.
4. Fernandex-Ortiz A., Badimon J.J., Falk E., Fuster V., Meyer B., Mailhac A.et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J. Am. Coll. Cardiol. 23:1994;1562-1569.
5. Falk E. Atherosclerosis and acute coronary events. Am. J. Cardiol. 82:1998;89T-94T.
6. Mann J.M., Davies M.J. Vulnerable plaque: relation of characteristics to degree of stenosis in human coronary arteries. Circulation. 94:1996;928-931.
7. Pritikin N. Optimal diet recommendations: a public health responsibility. Prev. Med. 11:1982;733-739.
8. Roberts W.C. Atherosclerotic risk factors - Are there ten or is there only one? Am. J. Cardiol. 64:1989;552-554.
9. Esselstyn C.B. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology). Am. J. Cardiol. 84:1999;339-341.
10. Campbell T.C., Parpia B., Junshi C. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study. Am. J. Cardiol. 82:1998;18T-21T.
11. Cleeman J.E. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA. 285:2001;2486-2491.
12. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J.et al. AHA dietary guideline - Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 102:2000;2296-2311.
13. McDougall J., Litzau K., Haver E., Saunders V., Spiller G.A. Rapid reduction of serum cholesterol and blood pressure by a twelve-day, very low fat, strictly vegetarian diet. J. Am. Coll. Nutr. 14(5):1995 (Oct.);491-496.
14. Barnard R.J. Effects of lifestyle modification on serum lipids. Arch. Intern. Med. 151:1991;1389-1394.
15. Diehl H.A., Mannerberg D. Regression of hypertension, hyperlipidemia, angina and coronary heart disease. Trowell H.A., Burkitt D.P. Western diseases: their emergence, prevention and reversibility. 1981;392-410 Edward Arnold, London.
16. Ornish D., Brown S.E., Scherwitz L.W., Billings J.H., Armstrong W.T., Ports T.A.et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet. 336:1990;129-133.
17. Ornish D., Scherwitz L.W., Billings J.H., Gould K.L., Merritt T.A., Sparler S.et al. Intensive lifestyle changes for reversal of coronary heart disease. Five-year follow-up of the lifestyle heart trial. JAMA. 280:1998;2001-2007.
18. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J.et al. Regular physical exercise and low-fat diet: effects on progression of coronary artery disease. Circulation. 86:1992;1-11.
19. Watts G.F., Lewis B., Brunt J.N.H., Lewis E.S., Coltart D.J., Smith L.D.R.et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas Atherosclerosis Regression Study (STARS). Lancet. 339:1992;563-569.
20. Haskell W.I., Alderman E.L., Fair J.M., Maron D.J., Mackey S.F., Superko H.R.et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 89:1994;975-990.
21. Esselstyn C.B., Ellis S.G., Medendorp S.V., Crowe T.D. A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice. J. Fam. Pract. 41:1995;560-568.
22. Esselstyn C.B. Resolving the coronary artery epidemic through plant-based nutrition. Prev. Cardiol. 4:2001;171-177.
23. Ornish D. Statins and the soul of medicine. Am. J. Cardiol. 89:2002;1286-1290.
24. Gould K.L., Ornish D., Scherwitz L.W., Brown S.E., Edons R.P., Hess M.J.et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term intense risk factor modification. JAMA. 254:1995;894-901.
25. Forrester J.S., Shah P.K. Lipid lowering versus revascularization - An idea whose time for testing has come. Circulation. 96:1997;1380-1382.
26. Kinlay S., Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am. J. Cardiol. 80(9A):1997;11I-16I.
27. Ezzati M., Lopez A., Rodgers A., Hoorn S., Murray C. Selected major risk factors and global and regional burden of disease. Lancet. 360:2002;1347-1360.
28. Vartiainen E., Jousilathi P., Alfthan G., Puska P. Community-based prevention of CAD: cardiovascular risk factor changes in Finland, 1972-1997. Int. J. Epidemiol. 29:2000;49-56.
29. Pietinen P., Lathi-Koski M., Vartiainen E., Puska P. Nutrition and cardiovascular disease in Finland since the early 1970s: a success story. J. Nutr. Health Aging. 5(3):2001;150-154.
30. Puska P. Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland. Public Health Medicine. 4(1):2002;5-7.
31. Stokols D.A. Translating social-ecological theory into the guidelines for community health promotion. Am. J. Health Promot. 10:1996;282-297.
32. Rosenstock I., Strecher V., Becker M. Social learning theory and the health belief model. Health Ed. Quart. 15(2):1988;175-183.
33. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham heart disease prediction score. JAMA. 286:2001;180-187.
34. American Diabetes Association Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. (Suppl 1):2003;S5-S20.
35. Boecker W., Roessner A., Schneider C. Das Herz. Boecker W., Denk K., Heintz T. Pathologie. 1997;125-132 Urban and Schwarzenberg Verlag, München.
36. Wirsam B., Hahn A., Uthus E., Leitzmann C. Fuzzy sets and fuzzy decision making in nutrition. Eur. J. Clin. Nutr. 51:1997;86-96.
37. Metropolitan Life Insurance Tables. This table is recognized by some respected researchers as being more representative of ideal weights than current tables ;1959 [W. Castelli, personal communication, 2003].
38. Anderson J.T., Jacobs D.R., Foster N., Keys A. Scoring systems for evaluation of dietary pattern effect on serum cholesterol. Prev. Med. 8:1979;525-533.
39. Ornish D. Avoiding revascularization with lifestyle changes: the multicenter lifestyle demonstration project. Am. J. Cardiol. 82:1998;72T-76T.
40. Connor W.E., Connor S.L., Katan M.B., Grundy S.M., Willett W.C. Should a low-fat, high carbohydrate diet be recommended for everyone? NEJM. 337:1997;562-567.
41. Lichtenstein A.H., VanHorn L. Very low fat diets. Circulation. 98:1998;935-939.
42. Conner W.E., Carqueira M.T., Connor R.W., Wallace R.B., Malinow M.Y., Cardorph R. The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico. Am. J. Clin. Nutr. 31:1978;1131-1142.
43. Wilson W.F., Larson M.G., Castelli W.P. Triglycerides, HDL-Cholesterol, and coronary artery disease: A Framingham update on their interrelations. Can. J. Cardiol. 10(Suppl):1994;58-98.